Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Protocols in Pharmacology|February 2, 2012
Monocrotaline-induced pulmonary hypertension in Wistar ratsMarkus Rey, Patrick Hess, Martine Clozel
The Journal of Pharmacology and Experimental Therapeutics|July 28, 2010
Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric functionKeith Morrison, Roland Ernst, Patrick Hess, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 4, 2005
The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic ratsMartine Clozel, Patrick Hess, Changbin Qiu, et al.
Journal of Cardiovascular Pharmacology|May 21, 2015
Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB ReceptorsMarc Iglarz, Pauline Steiner, Daniel Wanner, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in ratsMartine Clozel, Patrick Hess, Markus Rey, et al.
Journal of the American College of Cardiology|January 5, 2002
Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarctionMartine Clozel, Changbin Qiu, Chang-Shen Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonistsMartin H Bolli, Christoph Boss, Martine Clozel, et al.
Plos One|September 27, 2013
Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulatorMarkus Rey, Patrick Hess, Martine Clozel, et al.
Journal of Cardiovascular Pharmacology|June 27, 2003
Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the ratShuang-Shuang Ding, Changbin Qiu, Patrick Hess, et al.
Life Sciences|March 4, 2014
Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertensionMarc Iglarz, Alexandre Bossu, Daniel Wanner, et al.
Pageof 5